Harvard Bioscience Inc. Watch

from 8-K 72 pages Purchase Agreement by and Among Thomas Scientific, LLC, Denville Scientific, Inc., and Harvard Bioscience, Inc. Dated as of January 22, 2018

from 8-K 93 pages Agreement and Plan of Merger by and Among Harvard Bioscience, Inc. and Plymouth Sub, Inc. and Data Sciences International, Inc. and the Stockholder Representative Dated as of January 22, 2018 Agreement and Plan of Merger

from 10-K 43 pages Stuttgart Statements Given on October 1st, 2014

from 8-K 72 pages Plan of reorganization, merger, acquisition or similar

from 8-K 73 pages Geschehen Zu Stuttgart Am 8. Januar 2015 - I. W. Achten Januar Zweitausendfünfzehn - Executed in Stuttgart on This 8th Day of January 2015 - In Words Eighth Day of January Two Thousand Fifteen - Vor Mir, Dem Before Me, the Notar/Notary Rudolf Bezler Mit Dem Amtssitz in With His Official Residence at 70469 Stuttgart, Rheinstahlstrasse 3, Erscheinen Heute in Meinen Kanzleiräumen: There Appear Today in My Office: 1. Herr/Mr. Dr. Peter Schulze, Geboren Am/Born 25. November 1939, Geschäftsansässig in/Business Resident at 67466 Lambrecht, Wiesenstrasse 71, - Deutscher Staatsangehöriger/German Citizen -, - Ausgewiesen Durch Amtlichen Lichtbildausweis/Identified by Official Id With Photo -; 2. Herr/Mr. Jeffrey Anthony Duchemin, Geboren Am/Born 19. Oktober 1965, Wohnhaft in/Resident in 14 Eastland Terrace, Haverhill, Massachusetts 01830, USA, - Amerikanischer Staatsangehöriger/American Citizen -, - Ausgewiesen Durch Amtlichen Lichtbildausweis/Identified by Official Id With Photo -. (Im Folgenden Die "Erschienenen" Genannt). (Hereinafter Referred to as the "Persons Appearing"). Der Erschienene Zu Ziffer 1 Erklärt, Er Handele Nachfolgend Sowohl Im Eigenen Namen Als Auch in Seiner Eigenschaft Als Einzelvertretungsberechtigter Und Von Den Beschränkungen Des § 181 Bgb Befreite Geschäftsführer Für Die the Person Appearing Ad 1) Declares That He Is Acting in His Own Name and in His Capacity as Managing Director With Sole Power of Representation and Released From the Restrictions of § 181 German Civil Code (Bürgerliches Gesetzbuch) on Behalf of Dr. Peter Schulze Verwaltungs-Gmbh Mit Dem Sitz in Lambrecht/Pfalz, Eingetragen Im Handelsregister Des Amtsgerichts Ludwigshafen Am Rhein Unter Hr B 42892 (Postanschrift: Wiesenstrasse 71, 67466 Lambrecht), Dr. Peter Schulze Verwaltungs-Gmbh With the Statutory Seat in Lambrecht/Pfalz, Registered in the Commercial Register of the Local Court of Ludwigshafen Am Rhein Under Hr B 42892 (Mailing Address: Wiesenstrasse 71, 67466 Lambrecht),

from 8-K 48 pages Stock Purchase Agreement Among Harvard Bioscience, Inc. Triangle Biosystems, Inc. the Sellers Party Hereto and the Sellers’ Representative Named Herein Dated as of October 1, 2014

from 8-K 44 pages Stuttgart Statements Given on October 1st, 2014

from 8-K 55 pages Separation and Distribution Agreement by and Between Harvard Bioscience, Inc. and Harvard Apparatus Regenerative Technology, Inc. Dated as of October 31, 2013

from 8-K 50 pages Asset Purchase Agreement by and Among Dac Acquisition Holding, Inc., Harvard Bioscience, Inc., Denville Scientific, Inc., and Walter Demsia and Ryan Sharp September 2, 2009

from 8-K 46 pages Asset Purchase Agreement Among Union Biometrica, Inc., as Seller and Harvard Bioscience, Inc., as Parent and Ubio Acquisition Company, as Purchaser Dated as of September 30, 2008

from 8-K 51 pages Asset Purchase Agreement

from 8-K 36 pages Stock Purchase Agreement Among Kd Scientific Inc., Ken Dunne, and Harvard Bioscience, Inc., Dated as of March 3, 2004 1

from 8-K 35 pages Asset Purchase Agreement by and Among Genomic Solutions Acquisitions Limited, Biorobotics Limited, Biorobotics Group Limited and Matrix Technologies Corporation September 19, 2003 Asset Purchase Agreement

from 8-K 42 pages Asset Purchase Agreement by and Among Genomic Solutions Inc. and Genomic Instrumentation Services, Inc. D/B/a Genemachines February 28, 2003 Asset Purchase Agreement

from 8-K >50 pages Plan of reorganization, merger, acquisition or similar

from 8-K ~50 pages Plan of reorganization, merger, acquisition or similar

from S-1/A ~20 pages Plan of reorganization, merger, acquisition or similar

from S-1/A ~50 pages Plan of reorganization, merger, acquisition or similar